DE4326617C1 - Use of enzymatically active proteins, specific for cell wall lysis of Listeria - Google Patents
Use of enzymatically active proteins, specific for cell wall lysis of ListeriaInfo
- Publication number
- DE4326617C1 DE4326617C1 DE19934326617 DE4326617A DE4326617C1 DE 4326617 C1 DE4326617 C1 DE 4326617C1 DE 19934326617 DE19934326617 DE 19934326617 DE 4326617 A DE4326617 A DE 4326617A DE 4326617 C1 DE4326617 C1 DE 4326617C1
- Authority
- DE
- Germany
- Prior art keywords
- listeria
- food
- cell wall
- enzymatically active
- active proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000186781 Listeria Species 0.000 title claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 10
- 210000002421 cell wall Anatomy 0.000 title claims abstract description 5
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 4
- 230000009089 cytolysis Effects 0.000 title abstract description 3
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 241000186779 Listeria monocytogenes Species 0.000 claims abstract description 4
- 238000003860 storage Methods 0.000 claims abstract description 3
- 244000052616 bacterial pathogen Species 0.000 claims abstract 2
- 238000005202 decontamination Methods 0.000 claims abstract 2
- 230000003588 decontaminative effect Effects 0.000 claims abstract 2
- 241001515965 unidentified phage Species 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000002101 lytic effect Effects 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241000123769 Listeria virus A511 Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 235000008983 soft cheese Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Classifications
-
- A23L3/3571—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/05—Treating milk before coagulation; Separating whey from curd
- A23C19/054—Treating milk before coagulation; Separating whey from curd using additives other than acidifying agents, NaCl, CaCl2, dairy products, proteins, fats, enzymes or microorganisms
-
- A23C19/10—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
Abstract
Description
Verfahren zur selektiven Bekämpfung von Listeria monocytogenes in Lebensmitteln durch Phagolysine aus ListeriaphagenSelective control procedures Listeria monocytogenes in food Phagolysins from Listeriaphagen
Ein bekanntes Problem der Lebensmittelhygiene ist der Befall verschiedenster Lebensmittel mit dem humanpathogenen Bakterium Listeria monocytogenes. Wenn immungeschwächte Personen (Kranke oder alte Personen, schwangere Frauen) infiziert werden, können ernsthafte Erkrankungen mit Todes folge resultieren.A well-known problem of food hygiene is that Infestation of various foods with the human pathogenic Listeria monocytogenes bacterium. If immunodeficient People (sick or elderly, pregnant women) serious diseases can result in death result result.
Als Gegenmaßnahme wurde vorgeschlagen, dem Lebensmittel Lysozym aus Hühnereiklar (Zeitschrift "Applied and Environ mental Microbiology", Jahrgang 55, 1989, Seiten 631-638) oder von anderen Bakterien gebildete Bakteriozine (Zeitschrift "Applied and Environmental Microbiology", Jahrgang 54, 1988, Seiten 2349-2353) zur Bekämpfung oder Inhibition von Listerien in Lebensmitteln zu verwenden. Alle bisher vorgeschlagenen Verfahren sind jedoch fehlgeschlagen, weil die Zusatzstoffe biologischer oder chemischer Natur den Nachteil aufweisen, daß nicht nur Listeria, sondern auch viele oder sogar alle anderen Bakterien in den behandelten Produkten geschädigt oder getötet werden. Dies ist besonders nachteilig bei mit Starterkulturen hergestellten Lebensmitteln wie Käse oder Dauerfleischwaren; gerade diese sind aber besonders Listerien-gefährdet. Das im folgenden beschriebene Verfahren weist diese Nachteile nicht auf.As a countermeasure, it has been suggested the food Chicken egg lysozyme (magazine "Applied and Environ mental microbiology ", year 55, 1989, pages 631-638) or bacteriocins produced by other bacteria (magazine "Applied and Environmental Microbiology", year 54, 1988, Pages 2349-2353) for the control or inhibition of Listeria to use in food. All previously proposed However, procedures have failed because of the additives biological or chemical nature have the disadvantage that not only Listeria, but also many or even everyone else Bacteria in the treated products are damaged or killed become. This is particularly disadvantageous when using starter cultures manufactured foods such as cheese or permeate; but these are particularly vulnerable to Listeria. That in The following described method does not have these disadvantages on.
Insgesamt wurden zahlreiche Listeriaphagen beschrieben, darunter zahlreiche eigene Isolate, insbesondere der einzige virulente Listeriaphage A511 mit außerordentlich weitem Wirts bereich aus meinem Labor. Listeriaphagen injizieren ihre DNA in Listeria-Wirtszellen. Um nach Abschluß der Infektion die in der Wirtszelle neugebildeten Listeriaphagen freizusetzen, wird als finales Genprodukt während der Expression der späten Phagengene ein zellwandlytisches Enzym (Phagolysin) gebildet. Die Phagolysine von Listeriaphagen sind spezifisch aktiv gegen Zellwände von Bakterien der Gattung Listeria, wie in ent sprechenden Versuchen nachgewiesen wurde. Auch die externe Zugabe gereinigter Lysozyme in geringsten Konzentrationen zu Listeria führt zu deren Lyse und damit zum Zelltod (bakterio zide Wirkung). Die diesen Experimenten zugrundeliegende Präpa ration und Charakterisierung von Phagolysin aus Listeriaphagen sowie die begonnene Charakterisierung der zugehörenden Listeriaphagengenome wurde noch nirgendwo publiziert.In total, numerous Listeriaphagen have been described, including numerous own isolates, especially the only one virulent Listeriaphage A511 with extraordinarily wide host area from my laboratory. Listeriaphagen inject their DNA into Listeria host cells. To complete the infection after the infection to release the newly formed Listeriaphagen to the host cell as the final gene product during the expression of the late Phage genes formed a cell wall lytic enzyme (phagolysin). The Listeriaphagen phagolysins are specifically active against Cell walls of bacteria of the genus Listeria, as in ent speaking experiments has been demonstrated. Even the external one Add purified lysozyme in very low concentrations Listeria leads to their lysis and thus to cell death (bacterio zide effect). The preparation on which these experiments are based ration and characterization of phagolysin from Listeriaphagen as well as the started characterization of the associated Listeriaphagengenome has not been published anywhere.
Durch die Zugabe, Beimischung, Oberflächenbehandlung zu, in und von Lebensmitteln sowie in Lebensmittelproduktionsan lagen mittels der spezifisch wirksamen Phagolysine läßt sich eine selektive Eliminierung von Listerien erreichen, ohne andere (erwünschte) Organismen zu beeinträchtigen. Desweiteren kann eine andere Wirkung/Aktivität der Lysine in irgendeiner Weise ausgeschlossen werden. Damit sind Phagolysine als Lebens mittelzusatzstoffe qualifiziert. Das Phagolysin kann in einer standardisierten Form in die Rohstoffe gefährdeter Lebensmittel eingebracht, vor oder während gegebener Produktionsschritte dem Lebensmittel oder der Anlage zugesetzt, dem fertigen Endprodukt beigemischt oder aufgetragen werden, um eine Kontamination der abgegebenen Lebensmittel mit humanpathogenen Listerien zu bekämpfen.By adding, adding, surface treatment to, in and of food as well as in food production was by means of the specifically effective phagolysins achieve selective elimination of listeria without to affect other (desired) organisms. Furthermore may have another effect / activity of lysine in any Way to be excluded. So that phagolysins are as life qualified additives. The phagolysin can be in one standardized form in the raw materials of endangered food introduced before or during given production steps Food or plant added, the finished end product added or applied to contaminate the dispensed food with human pathogenic listeria fight.
Die biochemische Isolation wurde bis zur Reinheit durch geführt und das Phagolysin in o.a. Weise getestet. Aus mit Listeriaphagen infizierten Listeriazellen läßt sich mit dem getesteten Verfahren Phagolysin gewinnen. Ebenfalls kann mit diesen Verfahren Phagolysin aus rekombinanten, das Phagolysin- Gen enthaltenden Escherichia coli-Stämmen präpariert werden. Dazu werden die phagolysin-codierenden Gene aus den Genomen der Listeriaphagen isoliert und in Expressionsvektoren in dem Bakterium Escherichia coli subkloniert. Die Synthese von Proteinen mittels solcher Expressionvektoren kann in hoher Ausbeute in E. coli durchgeführt werden. The biochemical isolation was through to purity led and the phagolysin in o.a. Way tested. Off with Listeria cells infected with Listeria can be diagnosed with the method tested to obtain phagolysin. You can also use this process phagolysin from recombinant, the phagolysin Genes containing Escherichia coli strains can be prepared. For this purpose, the genes encoding the phagolysin from the genomes of Listeriaphagen isolated and in expression vectors in the Escherichia coli bacterium subcloned. The Synthesis of proteins using such expression vectors can be found in high yield in E. coli.
Produktion und Verkauf von Phagolysin-Präparaten an Lebensmittelhersteller. Bisher gibt es keine Alternative zu diesem Verfahren zur selektiven Bekämpfung von Listerien in Lebensmitteln.Production and sale of phagolysin preparations Food manufacturers. So far there is no alternative to this procedure for selective control of Listeria in Food.
Zur Herstellung von Weichkäsen des Typs "Rotschmiere käse", welcher oft mit Listerien kontaminiert ist, wird Kesselmilch zur Milchsäurebildung und Dicklegung mit Säuerungskulturen versetzt. Durch die schon hier erfolgende Zugabe von Phagolysinen können die schon in der Milch oder der Starterkultur vorhandenen Listerien entfernt werden. Im weiteren Verlauf der Käseherstellung wird wiederholt eine Oberflächen-Rotschmierekultur auf die Käse aufgebracht, welche mit Listerien kontaminiert sein kann. Eine gleichzeitige Applikation der Phagolysine zu diesem Zeitpunkt unterbindet wirkungsvoll die Entwicklung der pathogenen Organismen. Häufig erfolgen die Kontaminationen auch durch mangelhafte Lagerungs- und Reifungsbedingungen, wobei Listerien auf die Käse gelangen. Das Vorhandensein von Phagolysinen auf den Käseoberflächen würde diesen Rekontaminationen jedoch entgegenwirken. Da die Enzyme ein sehr spezifisches, ausschließlich gegen Listerien gerichtetes Aktivitätsspektrum aufweisen und keine Fremd aktivitäten haben, ist die Entwicklung der gewünschten Rot schmiereflora nicht gehindert. Die Aufnahme der Phagolysine durch den Verzehr der Käse ist deshalb ebenfalls völlig unbedenklich.For the production of soft cheese of the type "red smear cheese ", which is often contaminated with listeria Kettle milk for lactic acid formation and thickening with Acidification cultures offset. Because of the already happening here The addition of phagolysins can already in the milk or the Starter culture existing listeria can be removed. in the A further course of cheese making is repeated Surface red smear culture applied to the cheese, which may be contaminated with listeria. A simultaneous Application of the phagolysins is prevented at this time effective the development of pathogenic organisms. Frequently the contamination is also due to poor storage and ripening conditions, with listeria getting on the cheese. The presence of phagolysins on the cheese surfaces would counteract this recontamination. Since the Enzymes a very specific, only against Listeria have a directed activity spectrum and no foreign have activities is the development of the desired red smear flora not hindered. The uptake of phagolysins by eating the cheese is therefore also complete harmless.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19934326617 DE4326617C1 (en) | 1993-08-07 | 1993-08-07 | Use of enzymatically active proteins, specific for cell wall lysis of Listeria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19934326617 DE4326617C1 (en) | 1993-08-07 | 1993-08-07 | Use of enzymatically active proteins, specific for cell wall lysis of Listeria |
Publications (1)
Publication Number | Publication Date |
---|---|
DE4326617C1 true DE4326617C1 (en) | 1994-06-30 |
Family
ID=6494720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19934326617 Expired - Fee Related DE4326617C1 (en) | 1993-08-07 | 1993-08-07 | Use of enzymatically active proteins, specific for cell wall lysis of Listeria |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE4326617C1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000011472A2 (en) * | 1998-08-20 | 2000-03-02 | Siegfried Scherer | Cells using specific domains that bind to the cell walls (cbd) of proteins binding to the drawn cell walls |
WO2001050866A2 (en) * | 2000-01-11 | 2001-07-19 | Intralytix, Inc. | Method and device for sanitation using bacteriophages |
WO2004004495A1 (en) * | 2002-07-08 | 2004-01-15 | Exponential Biotherapies, Inc. | Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
WO2014037589A3 (en) * | 2012-12-06 | 2015-05-07 | Dsm Ip Assets B.V. | New antimicrobial compositions |
-
1993
- 1993-08-07 DE DE19934326617 patent/DE4326617C1/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
Applied and Environmental Microbiology, Vol. 55, No. 3, S. 631-638, 1989 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000011472A2 (en) * | 1998-08-20 | 2000-03-02 | Siegfried Scherer | Cells using specific domains that bind to the cell walls (cbd) of proteins binding to the drawn cell walls |
WO2000011472A3 (en) * | 1998-08-20 | 2000-06-22 | Siegfried Scherer | Cells using specific domains that bind to the cell walls (cbd) of proteins binding to the drawn cell walls |
WO2001050866A2 (en) * | 2000-01-11 | 2001-07-19 | Intralytix, Inc. | Method and device for sanitation using bacteriophages |
WO2001050866A3 (en) * | 2000-01-11 | 2002-02-07 | Intralytix Inc | Method and device for sanitation using bacteriophages |
EP1421855A2 (en) * | 2000-01-11 | 2004-05-26 | Intralytix Inc. | Method and device for sanitation using bacteriophages |
EP1421855A3 (en) * | 2000-01-11 | 2004-07-14 | Intralytix Inc. | Method and device for sanitation using bacteriophages |
WO2004004495A1 (en) * | 2002-07-08 | 2004-01-15 | Exponential Biotherapies, Inc. | Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
US7438901B2 (en) | 2002-07-08 | 2008-10-21 | Exponential Biotherapies, Inc. | Virulent phages to control Listeria monocytogenes in foodstuffs and in food processing plants |
US8034552B2 (en) | 2002-07-08 | 2011-10-11 | E.B.I. Food Safety B.V. | Virulent phages to detect Listeria monocytogenes in foodstuffs and in food processing plants |
WO2014037589A3 (en) * | 2012-12-06 | 2015-05-07 | Dsm Ip Assets B.V. | New antimicrobial compositions |
US9609876B2 (en) | 2012-12-06 | 2017-04-04 | Dsm Ip Assets B.V. | Antimicrobial compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60309882T2 (en) | VIRULENT PHARMACIES FOR COMBATING LISTERIA MONOCYTOGENES IN FOOD AND FOOD PROCESSING OPERATIONS | |
DE68927189T2 (en) | Medicines containing bacteriocin containing lanthionine for use as bactericides | |
DE69233152T2 (en) | Bacteriophage lysines and their applications for the destruction and testing for bacteria | |
DE69504037T2 (en) | ANTIVIRAL OR ANTIFUNGAL COMPOSITION AND METHOD | |
DE69733951T2 (en) | WIDE-SPECTRUM PREVENTION AND REMOVAL OF MICROBIAL FOOD DIFFICULTIES THROUGH QUARTER AMMONIUM COMPOUNDS | |
DE69220679T2 (en) | ANTIBACTERIAL AGENT AND TREATMENT OF ITEMS WITH THIS | |
DE69821995T2 (en) | ANTIMICROBIAL COMPOSITION | |
DE69025953T2 (en) | PHARMACEUTICAL PREPARATION FOR CONTROLLING PATHOGENIC INTESTINAL BACTERIA | |
Seeliger | Apathogene Listerien: L. innocua sp. n.(Seeliger et Schoofs, 1977) | |
DE69629691T2 (en) | METHOD FOR CONTROLLING ANTIBIOTIC-RESISTANT GRAMPOSITIVE BACTERIA AND TREATING INFECTIONS | |
DE3783208T2 (en) | METHOD OF FOOD OF ANIMAL ORIGIN. | |
EP2103308A1 (en) | Method for producing a mixture of bacteriophages and its use in therapy of antibiotic-resistant staphylococci | |
EP1171000B2 (en) | Novel protective cultures and use thereof for preserving foodstuffs or feedstuffs | |
DE69007831T2 (en) | Bioactive product; Compositions and substances that contain this bioactive product. | |
DE4326617C1 (en) | Use of enzymatically active proteins, specific for cell wall lysis of Listeria | |
DE69002024T2 (en) | Bioactive lactoferrin derivatives. | |
DE69305267T2 (en) | Composition for the treatment of mastitis and metritis | |
DE69319503T2 (en) | Lactococcus that produce various bacteriocins and compositions containing them | |
El-Sheekh et al. | Antimicrobial activity of the cyanobacteria Anabaena wisconsinense and Oscillatoria curviceps against pathogens of fish in aquaculture | |
DE69028520T2 (en) | PREPARATION OF MEDICINAL PRODUCTS IN TONSILLITIS TREATMENT | |
DE69632373T2 (en) | Selective media for cultivating and isolating gram-negative bacteria, antibiotic composition | |
EP0380675A1 (en) | Method for making sour-milk products | |
DE69101400T2 (en) | Antimicrobial compositions with a synergistic effect. | |
DE947827C (en) | Process for the preservation of decomposable substances | |
DE1016704B (en) | Process for the separation of tetracycline from its mixtures with chlortetracycline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8100 | Publication of the examined application without publication of unexamined application | ||
D1 | Grant (no unexamined application published) patent law 81 | ||
8322 | Nonbinding interest in granting licenses declared | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |